Gabriglobin is an immunologically active protein fraction containing a wide range of antibodies isolated from human plasma or serum of donors screened for the absence of antibodies to human immunodeficiency virus (HIV-1, HIV-2), hepatitis C virus and hepatitis B surface antigen B. The active drug component is dianabol cycle G, having an activity of antibodies of different specificities.
The drug is not exposed to chemical or enzymatic treatment does not contain preservatives and antibiotics. Stabilizer -. Maltose
At intravenous infusion the bioavailability is 100%. dianabol cycle G passes through the placenta and passes into breast milk. The maximum concentration of antibody in the blood is maintained for 21 days. Patients with primary agammaglobulinemia hypo- or half-life of more than 32 days.
Indications for use .
Severe forms of bacterial and viral infections.
Postoperative complications accompanying bacteremia and septikopiemicheskimi states.
The primary antibody deficiency syndrome: agamma- or hypogammaglobulinemia (congenital form, the period of physiological deficiency in newborns). Secondary antibody deficiency syndrome.
Blood diseases, the effects of immunosuppressive therapy, acquired immunodeficiency (AIDS), particularly in children infected with human immunodeficiency virus.
Pregnancy and lactation . During pregnancy and lactation is administered only under strict indications, where the intended benefits to the mother outweighs the potential risk to the child.
Hypersensitivity reactions or severe systemic reaction to human blood products in history.
Anaphylactic shock to human blood products in history in cases of severe sepsis.
Giperchuvstvitelyyust (including maltose), immune deficiency of IgA.
Precautions – severe heart failure, diabetes, renal insufficiency.
Dosage and administration .
The dianabol cycle for intravenous use only in the hospital through the infusion system. Before the introduction of the vials was kept at (20 + 2) ° C for at least 2 hours. Cloudy and containing precipitate solutions are not subject to the application.
The dose and frequency of administration depends on the indication for use.
For children, a single dose of 3 to 4 ml per 1 kg of body weight. dianabol cycle is administered intravenously at a rate of 8-10 drops per minute.
Infusion administered daily for 3-5 days.
Adult single dose is 25-50 ml. dianabol cycle intravenously administered in the first 10-15 minutes at a rate of 15-20 drops per minute, then at a rate of 30-40 drops per minute. Faster maintenance can cause the development kollaptoidnoy reaction. The course of treatment consists of 3-10 transfusions carried out after 24 – 72 hours (depending on the severity of the disease).
Side effects .
In the first days after administration of the drug may be a slight increase in body temperature, allergic reactions.
Sometimes there are headache, dizziness, dyspepsia, arterial hypo- or hypertension, tachycardia, shortness of breath.
In extremely rare cases, if you are hypersensitive may develop anaphylactic reactions .
Interaction with other medicinal products .
Transfusion therapy dianabol cycle for intravenous administration may be combined with other drugs, such as antibiotics.
The introduction of dianabol cycle may weaken (for 1.5-3 months) effect of live vaccines against viral diseases such as measles, rubella , mumps and chicken pox (vaccinations indicated vaccines should be carried out not earlier than 3 months). After administration of large doses of dianabol cycle its effect can last in some cases up to a year.
Do not use simultaneously with calcium gluconate in infants.
Special instructions .
Persons suffering from autoimmune diseases (diseases of the blood, connective tissue, jade), the drug should be administered on a background of appropriate therapy.
Immune globulin passes into breast milk and may contribute to the transfer of a newborn protective antibodies.
After the introduction of the drug should be monitored for the condition of the patient at least 30 minutes.
in the room where the injected drug, there is a means of antishock therapy.
With the development of anaphylactoid reactions used antihistamines, steroids and agonists.
A temporary increase of antibodies in the blood after administration of dianabol cycle may account for false-positive results of serological tests.
Do not exceed the speed of intravenous administration due to development opportunities collaptoid reactions. bodybuilding trainers testosterone enanthate australia bodybuilding injection